ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ CHIẾU ĐÈN VÀNG DA TĂNG BILIRUBIN GIÁN TIẾP Ở TRẺ SƠ SINH TẠI KHOA SƠ SINH BỆNH VIỆN NHI HẢI DƯƠNG NĂM 2025

Abstract

Objectives: To describe the clinical and paraclinical characteristics and to evaluate the outcomes of phototherapy in neonates with indirect hyperbilirubinemia–related jaundice at Hai Duong Children’s Hospital in 2025. Subjects and methods: A retrospective cross-sectional descriptive study was conducted on 92 neonates diagnosed with indirect hyperbilirubinemia–related jaundice and treated with phototherapy at the Neonatal Department from January 1, 2025 to September 30, 2025. Epidemiological, clinical, paraclinical characteristics and treatment outcomes were collected and analyzed using SPSS 22.0. Results: Male neonates accounted for 57.6%; full-term infants accounted for 84.8%. Most neonates developed jaundice after 72 hours of age (54.3%). Jaundice involving Kramer zones 4–5 accounted for 88.0%. Common causes included suspected ABO blood group incompatibility (22.8%), prematurity (15.2%), neonatal infection (8.7%), and G6PD deficiency (6.5%). A total of 78.3% of neonates had total serum bilirubin levels <340 µmol/L. Phototherapy was successful in 100% of cases, with an average duration of approximately 72 hours. Adverse effects were uncommon, mainly mild skin rash (6.5%). Conclusion: Phototherapy is an effective and safe treatment for indirect hyperbilirubinemia–related neonatal jaundice. Early detection and timely initiation of treatment help reduce the risk of neurological complications.